PERCEVAL ™

First Patient Enrolled in the PERSIST-AVR Trial at CHU Brabois, University of Lorraine, Nancy – France

Discover more

MEMO 3D RECHORD

LivaNova receives regulatory approval in Canada for its innovative Memo 3D ReChord annuloplasty ring for mitral valve repair

Discover more

PERCEVAL

LivaNova announces the first U.S. implant of Perceval, the only sutureless valve for aortic valve replacement surgery

Discover more

SOLO SMART

LivaNova receives regulatory approval in Japan for the Solo Smart stentless tissue aortic valve

Discover more

CROWN PRT ™

LivaNova announces FDA approval of stented heart valve CROWN PRT ™ for aortic valve disease

Discover more

KORA 250 now approved in Japan

World’s smallest full body MRI conditional pacing system with extended longevity and proprietary technologies designed to improve patient outcome

Discover more

Latest News

Jul 7, 2016

LivaNova to Host Conference Call for Second-Quarter 2016 Results

READ MORE

Jul 6, 2016

LivaNova PLC Sets Operating Model and Supporting Organization

READ MORE

Jun 3, 2016

LivaNova PLC to Present at the Goldman Sachs Healthcare Conference

READ MORE

May 5, 2016

SonR: 35% Risk Reduction in Heart Failure Hospitalization

READ MORE

May 4, 2016

LivaNova Reports First Quarter 2016 Results

READ MORE

In the Spotlight

Version unknown | Revision 91534 | Status unstable | SessionId 937B5D7D8160B0A45488920CFD977130.jvm0